Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

Biotechnology
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

$1.4B

Market Cap • 9/18/2025

2014

(11 years)

Founded

2022

(3 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country